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ABSTRACT
Type I CRISPR (Clustered Regularly Interspaced
Short Palindromic Repeats)–Cas (CRISPR-
associated) systems exist in bacterial and archaeal
organisms and provide immunity against foreign
DNA. The Cas protein content of the DNA interfer-
ence complexes (termed Cascade) varies between
different CRISPR-Cas subtypes. A minimal variant of
the Type I-F system was identified in proteobacterial
species including Shewanella putrefaciens CN-32.
This variant lacks a large subunit (Csy1), Csy2 and
Csy3 and contains two unclassified cas genes. The
genome of S. putrefaciens CN-32 contains only
five Cas proteins (Cas1, Cas3, Cas6f, Cas1821 and
Cas1822) and a single CRISPR array with 81 spacers.
RNA-Seq analyses revealed the transcription of this
array and the maturation of crRNAs (CRISPR RNAs).
Interference assays based on plasmid conjugation
demonstrated that this CRISPR-Cas system is active
in vivo and that activity is dependent on the recog-
nition of the dinucleotide GG PAM (Protospacer
Adjacent Motif) sequence and crRNA abundance.
The deletion of cas1821 and cas1822 reduced the
cellular crRNA pool. Recombinant Cas1821 was
shown to form helical filaments bound to RNA
molecules, which suggests its role as the Cascade
backbone protein. A Cascade complex was isolated
which contained multiple Cas1821 copies, Cas1822,
Cas6f and mature crRNAs.
INTRODUCTION
The arms race between viruses on one end and bacteria
and archaea on the other end resulted in the evolution
of diversified prokaryotic immune systems and viral coun-
termeasures (1,2). Prokaryotic genomes can contain adap-
tive immune systems, termed CRISPR (Clustered Regularly
Interspaced Short Palindromic Repeats)–Cas (CRISPR-
associated) (3,4), which utilize small RNAs to target foreign
genetic elements (5,6). Genomic CRISPR elements consist
of an array of short repeat sequences that are interspersed
with unique spacer sequences that can be derived from viral
genomes and conjugative plasmids (7–9). CRISPR arrays
are often located adjacent to a set of cas genes that are es-
sential for conferring immunity (10,11). The CRISPR–Cas
immune response can be divided into three stages. First,
upon infection of the host by a virus, a segment of a viral
genome, i.e. the protospacer, is integrated as a new spacer
into an expanding CRISPR array (12). This stage of the
immune response, termed acquisition, relies on the recog-
nition of a short signature sequence, the protospacer adja-
cent motif (PAM) in the viral DNA sequence (13,14). Next,
the CRISPR array is transcribed and processed into short
CRISPR RNAs (crRNAs) that contain a spacer sequence
flanked by parts of the repeats at their termini (15–19). The
crRNAs are integrated into CRISPR ribonucleoprotein (cr-
RNP) surveillance complexes that are formed by multiple
Cas proteins. These complexes utilize the crRNA guidance
to recognize and degrade foreign genetic material during
a recurring infection (6,17,20–22). The recognition of the
foreign genetic material is achieved via Watson–Crick base
pairing between the crRNA and the unwound target DNA
strand or target RNA sequence (23–25).
CRISPR–Cas systems are classified into three main types
based on the presence of the signature proteins Cas3 (Type
I), Cas9 (Type II) and Cas10 (Type III), respectively (10,26).
Only Cas1 and Cas2 are conserved in the vast majority of
the CRISPR–Cas systems and have been found to be es-
sential for the acquisition of new spacers (13,27,28). Type
I systems utilize a crRNP complex termed Cascade (or
CRISPR-associated complex for antiviral defense) to iden-
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tify targets (6,21,29), and Type II systems are character-
ized by the standalone nuclease Cas9 (30–32). In both cases,
the recognition of targets is dependent on the presence of a
PAM sequence (25,33,34). In contrast, Type III systems use
crRNP complexes that facilitate co-transcriptional ssRNA
and DNA cleavage in a PAM sequence-independent man-
ner (20,35,36).
The Type I Cascade crRNP complex has been studied
biochemically and structurally for subtype I-E (17,23,24),
and cryo-EM structures are available for Cascade com-
plexes of subtypes I-A, I-C and I-F (37–39). The 405 kDa
Type I-E Cascade from Escherichia coli has a characteris-
tic ‘seahorse-shape’ architecture and is formed by Cas5e,
Cas6e, Cas7 and two subtype-specific proteins Cse1 (large
subunit) and Cse2 (small subunit) (23,24,37). The complex
has an uneven protein stoichiometry of (Cas7)6–(Cse2)2–
(Cse1)1–(Cas5e)1–(Cas6e)1 and binds to a 61 nt-long cr-
RNA, which contains a 32 nt-long spacer flanked by 8
nt- and 21 nt-long repeat sequences, respectively. Cse1, the
large subunit protein of the Cascade complex, is involved
in PAM recognition and recruits Cas3 after target recog-
nition (17,37,40), whereas the small subunit protein Cse2
functions in stabilizing the R-loop by binding to the dis-
placed DNA strand (17,23,24). The Type I-E Cascade has a
helical backbone formed by six copies of Cas7 and contains
a groove in which the crRNA is bound and protected. Ad-
ditionally, the 3′- and 5′-ends of the crRNA are protected
by Cas6e and Cas5e, respectively (17,41). This general ar-
chitecture of the Cascade crRNPs appears to be conserved
for all Type I subtypes, even though their Cas protein com-
positions can differ considerably (42).
One apparent variation of this Cascade architecture is ev-
ident for a computationally identified subtype I-F variant
present in few beta- and gammaproteobacteria. This vari-
ant was first described for Photobacterium profundum SS9
(PBPRB1995-PBPRB1991) and was suggested to rely on
a minimal set of five Cas proteins (26). The system con-
tains Cas1, an integrase that mediates spacer acquisition
(43,44), Cas2–3, the target DNA nuclease, Cas6f, the en-
donuclease that generates mature crRNAs (18), and two ad-
ditional genes that show no apparent sequence similarity to
any known Cas protein families. Furthermore, a large sub-
unit could not be detected (26). We identified this minimal
CRISPR-Cas subtype in the Shewanella putrefaciens strain
CN-32 and experimentally verified crRNA maturation and
DNA interference activity in vivo. Recombinant production
of the Cas proteins revealed the presence of a Cascade com-
plex and allowed for the assignment of one unclassified Cas
protein into the Cas7 group. The two unclassified proteins
were shown to be required for a stable crRNA pool in S.
putrefaciens CN-32. Our results provide insights into the
reductive evolution of CRISPR–Cas systems and demon-
strate that a Cascade complex can function without a large
subunit.
MATERIALS AND METHODS
Bacterial strains and growth conditions
Bacterial strains and plasmids used in this study are listed
in Supplementary Table S1. E. coli strains DH5, DH5
pir and WM3064 were grown in LB medium at 37◦C. Me-
dia for the growth of the 2,6-diamino-pimelic acid (DAP)-
auxotroph E. coli WM3064 strain were supplemented with
300 M of DAP. E. coli strain BL21(DE3) pLysS was grown
either in LB or in NZ-amine (1% NZ-amine, 0.5% yeast ex-
tract and 1% NaCl) media at 37◦C until an OD600 of ∼0.6
was reached. Protein expression was induced by addition
of 1 mM Isopropyl -D-thiogalactopyranoside (IPTG) and
continuous growth at 18◦C. S. putrefaciens CN-32 was cul-
tured in LB medium at 30◦C. Media were supplemented
with 50 g/ml spectinomycin, 50 g/ml kanamycin, 50
g/ml ampicillin or 10% (w/v) sucrose.
Construction of cas gene deletion strains
S. putrefaciens CN-32 mutants with markerless in-frame
deletions or integrations were constructed using the primers
listed in Supplementary Table S2 and the suicide vec-
tor pNPTS138-R6KT (KanR) following the procedure re-
ported in (45). Briefly, appropriate ∼500 bp homologous
fragments of the up- and downstream regions of the tar-
get gene were amplified. For deletions, the codons encoding
the first and last four amino acids were retained. The re-
sulting PCR-derived DNA fragments were joined via over-
lap PCR, treated with appropriate restriction enzymes and
ligated with the equally digested pNPTS138-R6KT vector.
The resulting plasmids were sequenced and transferred to S.
putrefaciens CN-32 by conjugation from E. coli WM3064.
Target gene regions were replaced by the corresponding
modified version via sequential homologous crossover and
correct deletions were identified via colony PCR using ap-
propriate primers.
Point mutations were introduced into the S. putrefaciens
CN-32 gene Sputcn32 1822. To this end, the wild-type gene
sequence, along with 500 bp of upstream and downstream
sequences was cloned into pNPTS138-R6KT. Point muta-
tions were introduced into this plasmid by QuickChange
site-directed mutagenesis (Stratagene) using primers that
were designed using the Agilent QuickChange Primer De-
sign Tool. The plasmids carrying the point mutations were
applied for in-frame insertions in S. putrefaciens CN-32 as
described above.
RNA isolation, sequencing and Northern blot analysis
Nucleic acids were extracted from an overnight culture of
S. putrefaciens CN-32 using phenol/chloroform (1:1 phe-
nol pH 5 for RNA and pH 8 for DNA). The mirVana
RNA extraction kit (Ambion) was used to isolate small
RNAs (<200 nt) from total RNA. To ensure proper termini
for adapter ligation, 1 g of the small RNA preparation
was incubated with 10 U of T4 polynucleotide kinase (T4
PNK, Ambion) at 37◦C overnight, followed by 1 h incu-
bation at 37◦C in presence of 1 mM ATP. This treatment
ensures 5′-monophosphate termini suitable for RNA-Seq
library preparations. RNA libraries were sequenced by Il-
lumina HiSeq2000 sequencing at the Max-Planck Genome
Centre, Cologne.
Northern blot analyses required the extraction of 10 g
of total RNA from wild-type and cas gene-knockout strains
of S. putrefaciens CN-32. The RNA preparations were de-
natured (95◦C for 5 min) in formamide loading buffer and
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separated via electrophoresis on a 10% TBE–8 M urea poly-
acrylamide gels at 200 V for 1 h. The separated bands were
transferred to a nylon membrane (Roth) and subjected to
UV-crosslinking at 25 V for 2 h. DNA probes were radiola-
beled with 5′- [32P]-ATP using T4 PNK and incubated with
the membrane, which was pre-incubated at 42◦C for 30 min
with ULTRAhyb-Oligo buffer (Ambion). After overnight
hybridization at 42◦C, the membranes were washed two
times for 15 min with 2× SSC buffer and 0.1% SDS and
with 0.1× SSC and 0.1% SDS. Radioactive signals were de-
tected by phosphorimaging.
Conjugation-assays for DNA interference analysis
Target plasmids for conjugation assays were designed with
the primers listed in Supplementary Table S2. Individual
primer pairs were hybridized generating the sticky ends of
EcoRI and BamHI restriction sites that flanked the pro-
tospacer sequences. The primer pairs were phosphorylated
at the 5′-termini by T4 PNK, mixed and hybridized (95◦C
for 5 min, followed by slow cooling to room temperature).
The obtained DNA fragments were ligated into a linearized
pBBR1MCS2 (KanR) vector. Insertion of the fragment was
confirmed via sequencing.
The obtained plasmids were transformed into the donor
strain E. coli WM3064. Equal amounts of E. coli and S. pu-
trefaciens CN-32 strains overnight cultures were harvested.
The strains were suspended in 100 l of DAP-supplemented
LB medium and mixed before spotting a single drop on non-
selective LB agar supplemented with DAP. After overnight
incubation at 30◦C, the cells were washed from the plate
using 2 ml of nonselective LB. The mating mixture was
then washed three times with 1 ml of nonselective LB and
screened for conjugated S. putrefaciens CN-32 by plating
100 l of the mating mixture on LB plates supplemented
with Kan but lacking DAP. This procedure was performed
in triplicate and in parallel for the control plasmid without
protospacer sequences. The number of obtained colonies
was counted for conjugation of the plasmid with proto-
spacer (pT) and the control plasmid (pNT). Relative con-
jugation efficiency was calculated as pT/pNT ratio and the
transconjugant counts are detailed in Supplementary Table
S3.
Production and purification of recombinant proteins
The cas genes of S. putrefaciens CN-32 were amplified from
genomic DNA and cloned into gene expression vectors.
The cas6f gene was cloned into pET20b (AmpR) to gen-
erate Cas6f with a C-terminal His-tag. The gene cassette
cas1821, cas1822, cas6f was cloned into pRSFDuet; this
construct allows the simultaneous production of all three
proteins with only Cas1821 having an N-terminal His-tag
fusion. The individual cas1821 gene was cloned to pro-
duce a His-Sumo-tag fusion that was processed as pre-
viously described for Thermoproteus tenax Cas proteins
(22). Cas6f production was induced by addition of 1 mM
IPTG followed by overnight growth at 18◦C of the E. coli
BL21(DE3)pLysS host strain. Cell lysates were pepared by
sonication in a buffer containing 50 mM Tris-HCl pH 8.0,
500 mM NaCl, 5% glycerol, 1 mM dithiothreitol (DTT),
0.01% Triton X100 and 20 mM imidazole. Proteins were
purified on a HiTrap Ni-NTA column (GE Healthcare) in
a linear imidazole gradient ranging from 100 to 500 mM
imidazole. The Cas1821 protein was subjected to Ni-NTA
chromatography in a buffer containing 100 mM potassium
phosphate pH 7.5, 500 mM NaCl, 10% glycerol. A high-salt
washing step with a buffer including 1 M NaCl was added
before protein elution to remove nucleic acid contaminants.
The SUMO tag was cleaved using SUMO protease during
overnight dialysis at 4◦C in a buffer containing 50 mM Tris–
HCl pH 7.0, 100 mM NaCl and 10% glycerol. The protein
was further purified over a HiTrap Heparin Sepharose HP
column and size exclusion chromatography on a Superdex
200 column.
The production of recombinant Cascade required the
presence of the pRSFDuet vector containing the genes
cas1821, cas1822, cas6f and a pUC19 vector containing
the repeat-spacer4-repeat sequence from the CRISPR ar-
ray cloned downstream of a T7 RNA polymerase promoter.
The 100 nt transcript is processed by Cas6f into a 60 nt
crRNA. BL21(DE3)pLysS cells with both plasmids were
grown in the presence of ampicillin, kanamycin and specti-
nomycin. Protein and pre-crRNA production was induced
at an OD600 of 0.6 by addition of 1 mM IPTG, followed by
overnight growth at 18◦C. Cascade crRNP complexes were
purified via Ni-NTA chromatography in a buffer contain-
ing 50 mM Tris-HCl pH 7.0, 500 mM NaCl, 10% glycerol,
1 mM DTT and 20 to 500 mM imidazole. Size exclusion
chromatography was performed on a Superdex 200 column
(calibrated with a molecular weight standard kit (12 000–
200 000 Da, Sigma-Aldrich)) in a buffer containing 50 mM
HEPES-NaOH pH 7.0, 150 mM NaCl and 1 mM DTT.
Transmission electron microscopy of Cas1821
Purified protein samples were negatively stained with 2%
(w/v) uranyl acetate as described previously (22,46,47).
Subsequent electron microscopy was carried out with
a JEOL JEM-2100 transmission electron microscope
equipped with a LaB6 cathode at 120 kV (JEOL, Tokyo,
Japan). Electron micrographs were taken with a 2k × 2k
fast-scan CCD camera F214 combined with EM-Menu 4
(TVIPS, Gauting, Germany).
RESULTS
Identification of a minimal CRISPR-Cas subtype in S. putre-
faciens CN-32
A minimal Type I-F variant CRISPR–Cas subtype was first
described for Photobacterium profundum (PBPRB1995-
PBPRB1991) (26). The activity of this unusual system has
not been evaluated experimentally. We identified a simi-
lar system in S. putrefaciens CN-32 (Figure 1). S. putre-
faciens CN-32 harbors a single CRISPR array with 81
spacers and only five cas genes: cas1 (Sputcn32 1819),
cas3 (Sputcn32 1820), cas6f (Sputcn32 1823), cas1821 and
cas1822. The comparison of this system with the subtype I-
F system present in the Shewanella putrefaciens strain W3–
18–1 illustrates the loss of the large subunit and the possible
diversification of the Csy2 and Csy3 proteins (Figure 1A).
These CRISPR-Cas systems share 99–100% amino acid
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Figure 1. Comparison of CRISPR-Cas systems in S. putrefaciens strains. Schematic diagrams show the single CRISPR-Cas systems from S. putrefaciens
W3–18–1 (Sputw3181 2191- Sputw3181 2185, Type I-F) and S. putrefaciens CN-32 (Sputcn32 1819 – Sputcn32 1824, Type I-F variant). The N-terminal
94 amino acids of the Cas3 proteins share 100% aa identity. The C-terminal Cas3 portion and the Cascade components do not reveal significant protein
similarity.
identity for the flanking Cas1 and a CRISPR-array adjacent
DinG-helicase. In addition, the Cas6f (Csy4) endonuclease
and the N-terminal Cas2-like domain of the Cas2–3 nucle-
ase show significant sequence identity. Homology searches
of Cas1821 and Cas1822 revealed the presence of similar I-
F variant systems in few other beta- and gammaproteobac-
teria. These include the human pathogens Legionella pneu-
mophila (strain 2300/99 Alcoy) and Vibrio cholerae (strain
TM 11079–80).
The CRISPR array in S.putrefaciens CN-32 is transcribed
and processed in vivo
First, we aimed to show crRNA production of the minimal
Type I-F variant system. The small RNA fraction was iso-
lated from S. putrefaciens CN-32 and subjected to RNA-
Seq analyses. Sequencing of crRNAs required T4 PNK
treatment of the isolated small RNA molecules during Il-
lumina Hiseq2000 library preparation which indicates the
presence of crRNA 5′ OH termini. More than 11 million se-
quence reads were mapped to the S. putrefaciens reference
genome. The presence of all 81 crRNA transcripts could
be verified and precursor transcript processing generated
the expected 8 nt repeat tags at the crRNAs’ 5′-ends (5′-
CUUAGAAA-3′) and a 20 nt repeat tag at the 3′-termini
(Figure 2). 73 377 reads mapped to the CRISPR locus, in-
dicating a lower crRNA abundance in comparison to very
similar RNA-Seq studies for type I-A and type I-B systems
(16,22). A minimum free-energy five base pair stem-loop
was predicted in the 3′-repeat tags of all crRNAs, which
could explain the absence of additional 3′-terminal degra-
dation for most crRNAs (Figure 2). The abundance of the
individual crRNAs varied significantly.
We verified that the crRNAs are matured by Cas6f.
Sputcn32 1823 encodes a protein with 37% amino acid iden-
tity to Csy4 (Cas6f) from Pseudomonas aeruginosa. A se-
quence alignment of the two proteins verified a conserved
histidine residue at position 29 that was previously reported
to be essential for Cas6f activity (18). The purified recombi-
nant S. putrefaciens Cas6f protein showed endonuclease ac-
tivity and cleaved a 100 nt-long spacer-repeat–spacer tran-
script. This endonuclease activity was dependent on the cat-
Figure 2. Analysis of CRISPR RNA abundance and termini. The coverage
plot of S. putrefaciens CN-32 sequence reads (Illumina HiSeq2000) indi-
cates the variable abundance of individual crRNAs. Mature crRNAs con-
tained 5′-terminal 8 nt tags (5′-CUUAGAAA-3′) and 20 nt 3′-ends without
further trimming events (inset). Spacers that are marked with an asterisk
were tested for interference activity (see Figure 4)
alytic His29 residue, and a His29Ala point mutation abol-
ished the activity (Supplementary Figure S1).
The S. putrefaciens CRISPR–Cas systems shows in vivo in-
terference activity
Next, we assayed CRISPR-Cas-mediated DNA interfer-
ence activity in S. putrefaciens CN-32. The low abun-
dance of crRNAs required the establishment of a sensi-
tive conjugation-based in vivo assay (Figure 3A). Two con-
jugative plasmids were used: (i) a non-target control plas-
mid (pNT = pBBR1MCS2) and (ii) a target plasmid (pT)
containing the 13th spacer of the S. putrefaciens CN-32
CRISPR array (spacer13) and the PAM sequence ‘GG’ at
the 3′ end of the protospacer. The PAM sequence was se-
lected based on computational predictions by Mojica et al.
(14). In agreement, we could identify potential prophage
targets for spacer33 (∼97% identity between spacer and tar-
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Figure 3. Conjugation assays reveal DNA interference activity of the S. putrefaciens CN-32 CRISPR–Cas system. (A) The experimental set-up of the
conjugation assay is depicted. Two plasmids were used: (I) a control plasmid (pNT, plasmid non-target) and (II) a plasmid containing a PAM sequence
(light grey) and a sequence matching spacer 13 (dark grey) of the S. putrefaciens CN-32 CRISPR array (pT, plasmid target). The number of S. putrefaciens
CN-32 colonies carrying each plasmid was counted and the conjugation efficiency was determined. Interference is observed if pT/pNT is lower than 1 in
triplicate assays. (B) The pT/pNT ratio is calculated for conjugation assays into S. putrefaciens CN-32 wild type cells and strains containing deletions of
genes encoding Cas1, Cas3, Cas1821, Cas1822 and H-NS. Additionally, a Cas3 active site variant (HDmut, H156A/D157A) was tested. (C) Northern blot
analyses were performed with extracted total RNA from S. putrefaciens CN-32 wild-type and cas gene-knockout strains using a 5′- -[32P]-ATP labeled
probe complementary to the repeat sequence. A stable crRNA pool was absent in the S. putrefaciens CN-32 cas1821 and cas1822 strains.
get) and spacer34 (100% identity between spacer and tar-
get) using the tool CRISPRtarget (48). In both cases, the
di-nucleotide GG was found at the 3′ end of target strand
match. The two plasmids pNT and pT were conjugated
from E. coli WM 3064 into S. putrefaciens CN-32. In ad-
dition, markerless gene deletions were constructed for the
genes cas1, cas3, cas1821 and cas1822 and the two plasmids
were conjugated into these deletion strains. The colonies
carrying pNT or pT were counted and the relative conjuga-
tion efficiency was calculated as pT over pNT. Relative con-
jugation efficiency (pT/pNT) below 1 indicates interference
activity. Interference was observed in wild-type S. putrefa-
ciens CN-32 cells (Figure 3B) and the cas1 strain, which is
in agreement with an exclusive role of Cas1 in spacer acqui-
sition. In contrast, interference activity was not apparent in
the cas1821 and cas1822 strains, and was significantly
reduced in the cas3 strain and a strain carrying a Cas3 mu-
tant that lacks the HD nuclease motif. To investigate the rea-
son for this loss of interference activity, we assayed the cr-
RNA pool in these deletion strains. Total RNA was isolated
from the different S. putrefaciens CN-32 cells and North-
ern blot analyses were performed using a radioactively la-
beled probe against the crRNA repeat sequence (Figure
3C). The production of crRNAs was observed in wild-type
cells and the cas1- and cas3-deletion strains. However,
crRNAs were absent in the cas1821 and cas1822 strains.
These results are consistent with Cas6f generating mature
crRNAs, which are then bound by Cas1821 and Cas1822 to
maintain a stable crRNA pool in the cell. Thus, the absence
of interference activity for the cas1821 and cas1822
strains correlates with the absence of crRNAs in these cells.
Previous studies on the type I-E CRISPR-Cas system in
E. coli revealed that the heat-stable nucleoid-structuring (H-
NS) protein, a global transcriptional repressor, can regu-
late the expression of CRISPR-Cas systems (49). We con-
structed a S. putrefaciens CN-32 hns strain and observed
slightly increased interference activity (Figure 3B). A two-
fold increase in cas gene transcripts was detected via RT-
qPCR (Supplementary Figure S2), which could explain in-
creased interference.
The minimal subtype I-F variant CRISPR-Cas system rec-
ognizes PAM sequences and targets both DNA strands
Conjugation between the donor and the recipient cell re-
quires the transfer of one strand of plasmid DNA through
an intercellular cytoplasmic bridge, beginning at the origin
of transfer and progressing in 5′ to 3′ direction. The trans-
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Figure 4. Analysis of the DNA target specificity of the S. putrefaciens CN-
32 CRISPR–Cas system. Conjugation assays (see Figure 3) were used to
analyze plasmid DNA target variants for DNA interference in S. putrefa-
ciens CN-32 cells. (A) Interference was observed if the transferred DNA
strand contained a sequence complementary to the crRNA13 (sp13-GG)
or a sequence identical with spacer13 (sp13-GG*). Interference was evi-
dent for the wild-type and H-NS strains, which contained all cas genes.
However, the deletion of cas3 (Sputcn32 1820) or cas1822 abolished inter-
ference activity. The presence of the PAM sequence GG at the 3′ end of the
DNA target (5′-protospacer-PAM-3′) was essential for the interference ac-
tivity and PAM mutants (sp13-AG, sp13-GA, sp13-AA or sp13-CC) and
a 10 nt poly-A sequence disrupting crRNA/DNA complementarity (sp13-
polyA) were not targeted. (B) DNA interference activity was dependent
on spacer sequence or crRNA abundance (spacers 1,3,4,13,15,20,34, see
Figure 2).
ferred strand is converted into circular double-stranded
plasmid DNA in the recipient and a new strand is synthe-
sized in the donor to replace the transferred strand. In our
experimental setup, the transferred strand can be directly
targeted by the crRNA as it contains the sequence comple-
mentary to spacer13. To address if the minimal I-F vari-
ant system targets both DNA strands, a plasmid was con-
structed with the sequence of spacer13 on the transferred
strand. Thus, the complementary target of crRNA 13 exists
only after synthesis of the second strand in the recipient cell.
The relative conjugation efficiency (pT/pNT) for this plas-
mid in both wild-type and H-NS strains was comparable
to the previous construct (Figure 4). This suggests that the
I-F variant CRISPR–Cas system targets dsDNA.
Next, we aimed to investigate if the absence of a large
subunit has an effect on the recognition of PAM sequences
or the necessity for perfect crRNA/target complementar-
ity. Variants of the targeted plasmid were constructed that
contained PAM sequence mutations. These variants con-
tained the dinucleotides AG, GA, AA or CC at the 3′ end
of the spacer13 match on the target strand. In addition,
a plasmid was constructed with the PAM-adjacent 10 nt
of the protospacer (including the seed sequence) being re-
placed by a poly-A stretch. The relative conjugation effi-
ciency (pT/pNT) of these constructs highlighted a loss of
interference activity and demonstrated that PAM sequences
are recognized in S. putrefaciens CN-32 (Figure 4A).
The RNA-Seq analysis of crRNA production revealed
a highly variable crRNA abundance profile (Figure 2).
We investigated if the abundance of individual crRNAs is
correlated with the interference activity. Thus, we gener-
ated targeted plasmids with GG PAM sequences in which
the spacer13 target was replaced with spacer1, spacer3
(abundant crRNAs) or spacer4, spacer15, spacer20 and
spacer34 targets (low crRNA abundance). We performed
conjugation assays and verified that highly abundant cr-
RNAs (spacers1,3,13) yield efficient interference activity
(Figure 4B). In agreement, the observed absence of stable
crRNAs with spacer34 in S. putrefaciens CN-32 correlated
with a complete loss of interference activity. However, in-
terference activity was observed for crRNAs with spacer4,
spacer15 and spacer20 even though only minimal amounts
of these crRNAs were detected in our RNA-Seq analysis
(Figure 4B). In general, crRNAs with promoter-adjacent
spacers showed the highest interference activity. These re-
sults indicate that variable crRNA abundance is a factor
that can potentially influence the efficiency of DNA target-
ing.
Characterization of recombinant Cas1821 as a helical Cas-
cade backbone protein
The absence of observable crRNAs in the cas1821 and
cas1822 strains suggests that the encoded Cas proteins
are required for maintaining a stable crRNA pool in the
cell. Thus, these two proteins, Cas1821 and Cas1822, could
fulfill the roles of Cas7 and Cas5 proteins even though
sequence similarity calculations did not indicate them as
members of these Cas protein families (26). We attempted
to individually produce recombinant S. putrefaciens CN-32
Cas1821 and Cas1822 proteins in E. coli. The production of
Cas1822 did not yield soluble protein in various expression
conditions. However, soluble recombinant Cas1821 was
produced as a SUMO-tag fusion construct. The SUMO-
Cas1821 was purified via Ni-NTA chromatography and co-
eluted with bound nucleic acid contaminants. Therefore, a
high-salt washing step with a buffer including 1 M NaCl
was added before protein elution from the Ni-NTA column,
and a second cation exchange chromatography step was in-
cluded in the purification protocol. This procedure yielded
Cas1821 with a purity of >95% and without nucleic acid
contaminants. Gel-elution chromatography of Cas1821 re-
vealed a ∼35 kDa monomer (Supplementary Figure S3).
Electrophoretic mobility shift assays of Cas1821 with radi-
olabeled crRNA transcripts revealed a slow migrating band
indicating the crRNA-binding potential of Cas1821 (Fig-
ure 5A). This band disappeared upon addition of 1 g of
competitor yeast RNA, suggesting a non-specific interac-
tion. This behavior is in agreement with the observed non-
specific binding of E. coli contaminant nucleic acids. Re-
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Figure 5. Characterization of recombinant Cas1821 protein. (A) EMSA assays indicate the binding of 5′- [32P]-ATP labeled crRNA by 250 nM Cas1821
(lane 2) or 500 nM Cas1821 (lane 3). Bands were separated by 6% native PAGE. The RNA binding is unspecific and outcompeted by yeast total RNA. (B)
Transmission electron micrographs of negatively stained helical structures formed by RNA-bound recombinant Cas1821.
combinant Cas1821 bound to these contaminants eluted
near the void volume during gel-elution chromatography
(Supplementary Figure S3). These fractions were visualized
by electron microscopy and revealed the formation of long
helical filament-structures of varying length (Figure 5B).
These observations suggest that Cas1821 could fulfil the
role of Cas7 which was shown to form the helical Cascade
backbone filament after unspecific RNA binding in other
CRISPR-Cas subtypes (e.g. Type I-A, Type I-E).
In vivo characterization of potential DNA target interaction
partners
The absence of a large subunit implies that other Cas pro-
teins can substitute for its role(s) during DNA target inter-
action. However, even for previously investigated and re-
lated subtype I-F CRISPR–Cas systems, the role of the
large subunit (Csy1) is not clear, and it is not known which
Cas protein is responsible for PAM recognition (44). The
S. putrefaciens CN-32 CRISPR-Cas system is flanked by
a homolog of the DinG gene (Sputcn32 1824), an ATP-
dependent DNA helicase that was predicted to be a func-
tional component of Type I-U CRISPR-Cas systems (26).
To test if this protein plays a role in DNA interference,
we constructed a DinG strain. We did not observe a loss
of interference activity in our conjugation assays indicat-
ing that this DinG homolog does not promote DNA in-
terference and is not a component of subtype I-F variant
Cascade (Supplementary Figure S4). This is in agreement
with the observation that this DinG homolog is conserved
in S. putrefaciens strains without CRISPR-arrays or other
CRISPR-Cas subtypes.
It is possible that Cas1822 interacts with the DNA target,
as arginine residues are known to mediate DNA recogni-
tion in Cas proteins (50). A multiple alignment of Cas1822
proteins revealed conserved basic amino acids and a po-
tential Asp/Glu motif (Supplementary Figure S5). There-
fore, we assayed if mutations of conserved arginine residues
in Cas1822 have an effect on interference activity. We con-
structed point mutations of the cas1822 gene at the ap-
propriate positions to generate corresponding Ala substi-
tutions in Cas1822 in vivo, and these variants were tested
for interference activity. Interference was observed for
hns/R170A, hns/R225A and hns/E86A,D87A strains
(Figure 6A). A Northern blot analysis verified the presence
of mature crRNAs in these strains (Figure 6B). In con-
trast, the two strains hns/R60A and hns/R66A lacked
interference activity and stable crRNAs. We propose that
these arginine residues are required for Cascade formation
and crRNA protection. Finally, the two strains hns/R29A
and hns/R258A did not show interference activity even
though a stable crRNA pool was observed in the cell. Thus,
these arginine residues are possibly involved in either the
direct interaction with target DNA or with the Cas com-
ponent that recognizes the PAM motif. Both scenarios are
discussed below.
Production of recombinant subtype I-F variant Cascade
Finally, we aimed to verify that Cas1821 and Cas1822
are assembled into a Cascade complex. Thus, we trans-
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Figure 6. In vivo characterization of Cas1822 point-mutants. (A) S. putre-
faciens CN-32 strains carrying Cas1822 proteins with the indicated point
mutations were tested for DNA interference using the conjugation assay
(see Figure 3). (B) Northern Blot analyses with anti-repeat probes revealed
the cellular crRNA pool of these strains.
formed two plasmids into E. coli to facilitate the T7 RNA
polymerase-driven production of (i) a pre-crRNA tran-
script and (ii) the Cas proteins Cas1821, Cas1822 and Cas6f.
Only Cas1821 contains a His-Tag, which was successfully
used to purify a Cascade ribonucleoprotein complex from
E. coli. This complex was subjected to gel elution chro-
matography and the RNA and protein content of the frac-
tions was analyzed (Figure 7). A distinct peak revealed the
formation of a stable complex with an estimated size of ap-
proximately 215 kDa. The Cas1821 protein was overrepre-
sented in the complex which supports its role as Cascade
backbone. Cas1822 and Cas6f were co-purified and are sug-
gested to be the proteins that cap the 3′ hairpin tag (Cas6f)
and the 8 nt 5′ tag (Cas1822) of the crRNA. Indeed, mature
crRNA bands were co-purified in the Cascade fraction. This
verified that Cas6f processed the pre-crRNA transcript in
E. coli and likely loaded the Cascade complex. In addition,
Cas1821-Cas1822 dimers were detected which suggests that
these units are similar to the Cas5–Cas7 dimers observed
for the type I-A Cascade.
DISCUSSION
The Cas protein content of CRISPR-Cas systems varies be-
tween different subtypes. The Type I systems target DNA
and are characterized by a multi-protein DNA interference
complex termed Cascade. We analyzed the interference ac-
tivity of the S. putrefaciens CN-32 CRISPR-Cas system,
which contains a minimal Type I set of five Cas proteins.
Three of these proteins can be classified into subtype I-F
protein families. One of these proteins is Cas6, the endonu-
clease responsible for pre-crRNA cleavage reaction. Cas6
variants of the different CRISPR-Cas subtypes show differ-
ent RNA recognition and cleavage features. The S. putrefa-
Figure 7. Co-purification of a recombinant subtype I-F variant Cascade
complex. His-tagged Cas1821 co-eluted with Cas1822, Cas6f and mature
crRNA during gel-elution chromatography (fractions 4 and 5) which ver-
ified Cascade complex formation. Cas1821 filaments were observed in the
void volume (fractions 1 and 2). Dimers of Cas1821 and Cas1822 (fraction
8) were identified. SDS-PAGE (middle) and 8M urea PAGE (bottom) was
used to separate the protein and RNA content of the fraction indicated in
the gel-elution chromatogram (top).
ciens Cas6 enzyme is a Cas6f variant. A catalytic histidine
residues at position 29 was found to be essential for cleav-
age activity, similar to the well-characterized Cas6f of P.
aeruginosa (18). The mature crRNAs contain a standard 8
nt 5′ tag and a stable hairpin formed by the repeat sequence
at the 3′ end, which prevents further 3′-terminal trimming.
The 3′-terminal hairpin structures have also been found in
other subtypes and are e.g. described for crRNAs found in
E. coli and P. aeruginosa (6,18). In these systems, the corre-
sponding Cas6 enzymes remain stably associated with the
hairpin after cleavage and protect the crRNA from further
degradation (18,37,51). This stable interaction of Cas6f to
the crRNA is suggested to serve as a starting point for the
assembly of the Cascade backbone by several Cas7 copies
(17,23,24). This is suggested to allow Cas5 to bind and cap
the 5′ tag of the crRNA. Thus, these three proteins bind and
protect crRNA in Cascade and guarantee their stability and
their ability to form base pairs with target DNA.
We showed that the deletion of Cas1821 or Cas1822 abol-
ished interference activity in conjugation assays, which cor-
responded with the loss of an observable cellular crRNA
pool. Analyses of E. coli and Haloferax volcanii Cascade
structures and Pseudomonas aeruginosa Type I-F system ac-
tivity showed that Cas5 and Cas7 proteins are essential for
crRNA maintenance and stability (52–54). Thus, we pro-
pose that Cas1821 and Cas1822 can fulfill the roles of these
two proteins. Accordingly, recombinant Cas1821, Cas1822
and Cas6f could be co-purified in Cascade assemblies with
mature crRNAs. The non-specific RNA binding of Cas1821
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led to the formation of oligomeric structures that could be
visualized as helical filaments using electron microscopy.
The formation of helical filaments was previously reported
for Cas7 from Thermoproteus tenax, a sub-complex of Cas7
and Cas5a subunits from Sulfolobus solfataricus and for
Type I-E Cascade in E. coli (22,39). Thus, we conclude that
Cas1821 proteins build the helical backbone of the Cascade
structures and serve as Cas7 proteins. The observed for-
mation of Cas1821 and Cas1822 dimers suggest that these
could be the initial building blocks of Cascade, similar to
the Cas7 and Cas5a subunit dimers found in S. solfataricus.
Our RNA-Seq analyses indicated highly variable crRNA
abundance patterns. The general crRNA abundance was
lower than found for other subtypes, e.g. subtype I-B (M.
maripaludis) or subtype I-A (T. tenax) (16,22). Usually, the
most abundant crRNAs are the ones closest to the promoter
in the CRISPR leader regions (16,22,55). These crRNAs
contain the most recently acquired spacers. The variability
of crRNA abundance could be explained by the presence of
anti-crRNA sequences and internal promoters, which were
observed in other cases (56). These scenarios are not ap-
parent for the S. putrefaciens CRISPR array. It is plausible
that the Cascade loading efficiency differs for different cr-
RNAs. Additionally, pre-crRNA could form internal struc-
tures that would influence Cas6f cleavage site availability.
The assembly of crRNAs into Cascade complexes con-
taining multiple Cas1821 copies, Cas1822 and Cas6f high-
lights the universality of this architecture in Type I systems.
It is apparent that small and large subunits are missing in
this subtype I-F variant CRISPR-Cas system. We utilized a
conjugation assay to study if the loss of these subunits has
an influence on known features of Type I-mediated DNA
interference. However, we observed that this system tar-
gets dsDNA and depends on the presence of a PAM se-
quence as expected for a Type I CRISPR-Cas activity. The
PAM sequence was found to be GG and mutations in this
sequence resulted in the loss of interference activity. The
PAM sequence is shared with subtype I-F CRISPR-Cas
systems (14,57). We asked if undetected Cas proteins ex-
ist in the genomes of organisms that contain the subtype
I-F variant, which could fulfill the function of small and
large subunits. It should be noted that the small subunit
is also missing for subtype I-F CRISPR-Cas systems. The
subtype I-F variant CRISPR-Cas system was identified in
nine mesophilic beta- and gamma-proteobacteria: S. pu-
trefaciens (strains CN-32 & 200), Oligella ureolytica (strain
DSM 18253), Pseudoalteromonas tunicata (strain D2), Le-
gionella pneumophila (strain 2300/99 Alcoy), Oxalobacter
formigenes (strain OXCC13), P. profundum (strain SS9),
Vibrio cholerae (strain TM 11079–80) and Methylophaga
nitratireducenticrescens. Phylogenetic profiling did not re-
veal additional Cas proteins that co-evolved with the un-
usual Cascade assemblies. A homolog of a DinG helicase
was identified downstream of the CRISPR array, which
was reported to be part of Type I-U CRISPR-Cas system
(26). However, these enzymes are also found in related She-
wanella strains without CRISPR systems or with different
CRISPR-Cas subtypes. A deletion of the dinG gene did not
abolish the interference activity indicating that the encoded
protein is not required for subtype I-F variant Cascade ac-
tivity. In conclusion, we do not see any evidence for addi-
tional Cascade components that are not encoded in the min-
imal cas gene operon. To date, RNase III and PNPase are
the only non-Cas proteins that can be involved in confer-
ring CRISPR-Cas based immunity (58,59). Both proteins
play a key role in crRNA generation and are not involved
in DNA interactions. The large subunit of the subtype I-E
E. coli Cascade has been shown to interact with the PAM
motif and to recruit Cas3. In addition, both small and large
subunits are required for the stabilization of the crRNA-
target hybrid (23,60). The role of the large subunit (Csy1) of
subtype I-F CRISPR-Cas systems is not fully understood
yet. We hypothesize that either Cas1822 and/or Cas3 are
involved in DNA target PAM recognition. We showed that
the mutation of conserved arginine residues in Cas1822 in-
fluenced DNA interference activity even in the presence of
a stable cellular crRNA pool. Cas3 interacts with the DNA
and could provide additional DNA target selectivity. It is
interesting to note that the subtype I-F and subtype I-F
variant Cas3 enzymes contain an N-terminal portion that
resembles Cas2 (44). Only this region is conserved between
Cas3 enzymes found in different Shewanella strains, while
the larger C-terminal portion shows no apparent homol-
ogy. Thus, unexpected Cas3 functions could be encoded in
this part. The soluble recombinant production of S. putre-
faciens Cas1822 and Cas3 was not successful and we rely
on future studies of macromolecular Cascade structures to
pinpoint the molecular details of PAM recognition mecha-
nisms in subtype I-F and subtype I-F variant CRISPR-Cas
systems. The loss of large and small subunits might coincide
with the evolution of specialized minimal Type I Cascade
systems that still rely on PAM motif recognition for DNA
target specificity.
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